LIBERTY DEFENSE HOLDINGS LTD (SCAN.CA) Fundamental Analysis & Valuation

TSX-V:SCAN • CA53044R8672

Current stock price

6.85 CAD
-0.17 (-2.42%)
Last:

This SCAN.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. SCAN.CA Profitability Analysis

1.1 Basic Checks

  • SCAN had negative earnings in the past year.
  • SCAN had a negative operating cash flow in the past year.
  • In the past 5 years SCAN always reported negative net income.
  • SCAN had a negative operating cash flow in each of the past 5 years.
SCAN.CA Yearly Net Income VS EBIT VS OCF VS FCFSCAN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -130.96%, SCAN is doing worse than 86.96% of the companies in the same industry.
Industry RankSector Rank
ROA -130.96%
ROE N/A
ROIC N/A
ROA(3y)-159.03%
ROA(5y)-143.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SCAN.CA Yearly ROA, ROE, ROICSCAN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

  • SCAN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SCAN.CA Yearly Profit, Operating, Gross MarginsSCAN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600

0

2. SCAN.CA Health Analysis

2.1 Basic Checks

  • SCAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SCAN has been increased compared to 1 year ago.
  • The number of shares outstanding for SCAN has been increased compared to 5 years ago.
  • SCAN has a worse debt/assets ratio than last year.
SCAN.CA Yearly Shares OutstandingSCAN.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K
SCAN.CA Yearly Total Debt VS Total AssetsSCAN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

  • SCAN has an Altman-Z score of -13.91. This is a bad value and indicates that SCAN is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -13.91, SCAN is not doing good in the industry: 86.96% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -13.91
ROIC/WACCN/A
WACC12.18%
SCAN.CA Yearly LT Debt VS Equity VS FCFSCAN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M

2.3 Liquidity

  • SCAN has a Current Ratio of 0.46. This is a bad value and indicates that SCAN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SCAN has a Current ratio of 0.46. This is in the lower half of the industry: SCAN underperforms 78.26% of its industry peers.
  • A Quick Ratio of 0.34 indicates that SCAN may have some problems paying its short term obligations.
  • SCAN's Quick ratio of 0.34 is on the low side compared to the rest of the industry. SCAN is outperformed by 78.26% of its industry peers.
Industry RankSector Rank
Current Ratio 0.46
Quick Ratio 0.34
SCAN.CA Yearly Current Assets VS Current LiabilitesSCAN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

1

3. SCAN.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 29.49% over the past year.
  • Looking at the last year, SCAN shows a very strong growth in Revenue. The Revenue has grown by 63.38%.
EPS 1Y (TTM)29.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.15%
Revenue 1Y (TTM)63.38%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-75.01%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SCAN.CA Yearly Revenue VS EstimatesSCAN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 500K 1M 1.5M 2M
SCAN.CA Yearly EPS VS EstimatesSCAN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 -100 -200 -300 -400

0

4. SCAN.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • SCAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SCAN.CA Price Earnings VS Forward Price EarningsSCAN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SCAN.CA Per share dataSCAN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. SCAN.CA Dividend Analysis

5.1 Amount

  • No dividends for SCAN!.
Industry RankSector Rank
Dividend Yield 0%

SCAN.CA Fundamentals: All Metrics, Ratios and Statistics

LIBERTY DEFENSE HOLDINGS LTD

TSX-V:SCAN (4/15/2026, 7:00:00 PM)

6.85

-0.17 (-2.42%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-26
Earnings (Next)04-24
Inst Owners4.72%
Inst Owner ChangeN/A
Ins Owners1.13%
Ins Owner ChangeN/A
Market Cap13.56M
Revenue(TTM)2.44M
Net Income(TTM)-8.85M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.04
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-31.97
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-8.31
FCFYN/A
OCF(TTM)-8.19
OCFYN/A
SpS1.7
BVpS-1.27
TBVpS-2.77
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -130.96%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-159.03%
ROA(5y)-143.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.18%
Cap/Sales 7.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.46
Quick Ratio 0.34
Altman-Z -13.91
F-Score4
WACC12.18%
ROIC/WACCN/A
Cap/Depr(3y)44.5%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.15%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)63.38%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-75.01%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-81.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-86.94%
OCF growth 3YN/A
OCF growth 5YN/A

LIBERTY DEFENSE HOLDINGS LTD / SCAN.CA Fundamental Analysis FAQ

What is the fundamental rating for SCAN stock?

ChartMill assigns a fundamental rating of 0 / 10 to SCAN.CA.


Can you provide the valuation status for LIBERTY DEFENSE HOLDINGS LTD?

ChartMill assigns a valuation rating of 0 / 10 to LIBERTY DEFENSE HOLDINGS LTD (SCAN.CA). This can be considered as Overvalued.


Can you provide the profitability details for LIBERTY DEFENSE HOLDINGS LTD?

LIBERTY DEFENSE HOLDINGS LTD (SCAN.CA) has a profitability rating of 0 / 10.


How financially healthy is LIBERTY DEFENSE HOLDINGS LTD?

The financial health rating of LIBERTY DEFENSE HOLDINGS LTD (SCAN.CA) is 0 / 10.